骨髓源性生长因子调控的肺腺癌肿瘤发生与EGFR状态和癌症侵袭性相关的数据集

通过蛋白质组学分析肺腺癌中EGFR状态相关的差异蛋白,发现MYDGF作为阶段特异性生物标志物,数据涵盖组织和血清样本。

NIAID Data Ecosystem
浏览 31
蛋白质组学using quantitative proteomicstyrosine kinase inhibitorskey candidate biomarkerfunctional studies demonstratedderived growth factordependent biomarker assessmentsecreted mydgf promotedelevated mydgf levelstransformed lung adenocarcinomastrategies targeting wildspecific proteomic profilespersonalized treatment strategies
Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness

基本信息

模态
蛋白质组学
大小
0.00001258 GB
许可
CC BY-NC 4.0
创建/更新时间
2026-10-07
版本
v1

资源简介

骨髓源性生长因子调控的肺腺癌肿瘤发生与EGFR状态和癌症侵袭性相关的数据集

【一句话概览】

本数据集是 figshare 公开的组学数据集,收录 1 个文件、合计 12.58 KB,主题涵盖 using quantitative proteomics、tyrosine kinase inhibitors、key candidate biomarker、functional studies demonstrated、derived growth factor,可用于生物标志物发现与分子分型研究,CC BY-NC 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Myeloid-Derived

Growth Factor-Regulated Oncogenesis

in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness》。配套论文《Myeloid-Derived

Growth Factor-Regulated Oncogenesis

in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness》发表于 Journal of Proteome Research(2025),DOI:10.1021/acs.jproteome.5c00385。源站首次发布:2025-08-02。

【数据内容】

源站原始描述:Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have transformed lung adenocarcinoma (LUAD) treatment in EGFR-mutant (MT) patients, but strategies targeting wild-type (WT) EGFR tumors remain necessary. This study analyzed a diverse LUAD patient cohort with EGFR mutation statuses and wild-type profiles for ALK and KRAS to identify stage-specific biomarkers. Using quantitative proteomics and multiomics, we discovered 21 dysregulated proteins in early-stage EGFR-WT LUAD, identify…

【数据结构与技术规格】

文件数 1 个,合计 12.58 KB。pr5c00385_si_005.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,12.58 KB。数据集 DOI:10.1021/acs.jproteome.5c00385.s005。

【主题与分类】

源站学科分类:Biochemistry、Medicine、Cell Biology、Genetics、Chemical Sciences not elsewhere classified、Developmental Biology。主题标签:using quantitative proteomics、tyrosine kinase inhibitors、key candidate biomarker、functional studies demonstrated、derived growth factor、dependent biomarker assessment、secreted mydgf promoted、elevated mydgf levels、transformed lung adenocarcinoma、strategies targeting wild。

【适用方向】

组学数据适用于生物标志物发现与分子分型相关建模研究。

【获取与许可】

源站页面:https://acs.figshare.com/articles/dataset/Myeloid-Derived_Growth_Factor-Regulated_Oncogenesis_in_Lung_Adenocarcinoma_Is_Associated_with_EGFR_Status_and_Cancer_Aggressiveness/29815310

使用许可:CC BY-NC 4.0(https://creativecommons.org/licenses/by-nc/4.0/)。

规范引用:Hsiao, Ting-Feng; Wang, Chih-Liang; Wu, Yi-Cheng; Kuo, Chia-Yu; Lin, Ke-Wei; Chuang, Wen-Yu; et al. (2025). Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness. ACS Publications. Dataset

【使用注意】

· 源站最后修改于 2026-08-02,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "pr5c00385_si_005.xlsx" "https://ndownloader.figshare.com/files/56864891"

文件清单

  • pr5c00385_si_005.xlsx(12.58 KB)

文件总体积 12.58 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Epidermal growth
factor receptor (EGFR) tyrosine kinase
inhibitors
have transformed lung adenocarcinoma (LUAD) treatment in EGFR-mutant
(MT) patients, but strategies targeting wild-type (WT) EGFR tumors
remain necessary. This study analyzed a diverse LUAD patient cohort
with EGFR mutation statuses and wild-type profiles for ALK and KRAS
to identify stage-specific biomarkers. Using quantitative proteomics
and multiomics, we discovered 21 dysregulated proteins in early-stage
EGFR-WT LUAD, identifying myeloid-derived growth factor (MYDGF) as
a key candidate biomarker. Elevated MYDGF levels in tissue (n = 117) and serum (n = 196) correlated
significantly with cancer stage in EGFR-WT patients but not EGFR-MT
cases. Notably, a higher tumor-to-normal MYDGF ratio predicted a favorable
prognosis in early-stage EGFR-WT LUAD. Functional studies demonstrated
that MYDGF exerts distinct roles in cell viability and migration depending
on its cellular localization and the invasive potential of cancer
cells. Specifically, secreted MYDGF promoted a protumorigenic phenotype,
whereas excess intracellular MYDGF appeared to suppress the oncogenic
capacity of aggressive cancer cells. MYDGF knockdown and subsequent
proteomic analysis provided further insights into these context-dependent
functions. These findings highlight EGFR status- and stage-specific
proteomic profiles in LUAD, emphasizing the importance of context-dependent
biomarker assessment for personalized treatment strategies.

许可

CC BY-NC 4.0

引用

学术使用请引用 DOI 10.1021/acs.jproteome.5c00385.s005(source: https://acs.figshare.com/articles/dataset/Myeloid-Derived_Growth_Factor-Regulated_Oncogenesis_in_Lung_Adenocarcinoma_Is_Associated_with_EGFR_Status_and_Cancer_Aggressiveness/29815310)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案